BUDI (Bariatric UroDynamic Improvement)

Sponsor
University Hospital, Caen (Other)
Overall Status
Recruiting
CT.gov ID
NCT03509038
Collaborator
(none)
25
1
1
57.7
0.4

Study Details

Study Description

Brief Summary

In the population of obese women, the prevalence of urinary incontinence (UI) is around 70%. It was shown in the literature that weight loss by bariatric surgery allowed a significant improvement in the symptoms and impact on the quality of life of the IU. However, no prognostic factor for recovery has yet been identified and the pathophysiological mechanisms underpinning this improvement are not fully elucidated.

The main objective of this study is to highlight the urodynamic changes associated with the improvement of the symptom and quality of life scores in a population of incontinent obese women before and after bariatric surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Exploratory pathophysiology Study
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Urodynamic Evaluation of Incontinent Obese Women Before and After Weight Reduction by Bariatric Surgery : What Urodynamic Healing Factors? BUDI (Bariatric UroDynamic Improvement)
Actual Study Start Date :
Mar 13, 2018
Anticipated Primary Completion Date :
Jan 1, 2022
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Urinary incontinence before bariatric surgery

All patients with urinary incontinence before bariatric surgery will be addressed for a urodynamic exam

Other: Exploratory pathophysiology Study
Urodynamic tests before and after bariatric surgery in obese incontinent women before and after bariatric surgery

Outcome Measures

Primary Outcome Measures

  1. Urodynamic changes after bariatric surgery in obese incontinent women [24 months]

    to highlight the changes in urodynamic vesical pressure (cmH2O) associated with the improvement of urinary incontinence after bariatric surgery

  2. Urodynamic changes after bariatric surgery in obese incontinent women [24 months]

    to highlight the changes in urodynamic vesical sensations (cmH2O) associated with the improvement of urinary incontinence after bariatric surgery

  3. Urodynamic changes after bariatric surgery in obese incontinent women [24 months]

    to highlight the changes in urodynamic bladder-to-urethra pressure transmission (%) with cough associated with the improvement of urinary incontinence after bariatric surgery

  4. Urodynamic changes after bariatric surgery in obese incontinent women [24 months]

    to highlight the changes in urodynamic maximum urethral cloture pressure (cmH2O) associated with the improvement of urinary incontinence after bariatric surgery

Secondary Outcome Measures

  1. Urinary incontinence symptom improvement after bariatric surgery [24 months]

    Changes in ICIQ-SF (International Consultation on Incontinence Questionnaire - Short Form) scores (assessing frequency and quantity of urinary loss, ranging from 0 to 21) after weight loss in incontinent obese women

  2. Quality of life improvement after bariatric surgery [24 months]

    Measuring changes in Quality of life after weight loss with the Contilife questionnaire which specifically measures the impact of urinary incontinence on quality of life : activity of daily life

  3. Quality of life improvement after bariatric surgery [24 months]

    Measuring changes in Quality of life after weight loss with the Contilife questionnaire which specifically measures the impact of urinary incontinence on quality of life : self-image and emotional impact and sexuality)

  4. Quality of life improvement after bariatric surgery [24 months]

    Measuring changes in Quality of life after weight loss with the Contilife questionnaire which specifically measures the impact of urinary incontinence on quality of life : sexuality

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:

The research protocol will be proposed to all patients requiring bariatric surgery (gastric bypass or sleeve gastrectomy) and describing urinary incontinence according to the definition of the International Continence Society (ICS)

Exclusion Criteria:
  • minors under the age of 18

  • pregnant or lactating women

  • women not speaking French (important to understand and respond to questionnaires)

  • women who have not given their written consent

  • neurological diseases,

  • patients who have benefited from urinary incontinence surgery, prolapse treatment or pelvic surgery at risk of urodynamic modifications (extensive resection of deep endometriosis, pelvic wound surgery, pelvic radiation therapy).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pizzoferato Caen France 14000

Sponsors and Collaborators

  • University Hospital, Caen

Investigators

  • Principal Investigator: Anne-Cécile Pizzoferrato, MD, PhD, University hospital of Caen

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT03509038
Other Study ID Numbers:
  • 2017-A02121-52
First Posted:
Apr 26, 2018
Last Update Posted:
Aug 31, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 31, 2021